Form 4: Allovir Executive Vikas Sinha Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Vikas Sinha, President and CFO of Allovir, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On May 3, 2024, Vikas Sinha, President and CFO of Allovir, sold 4,957 shares of common stock at a price of $0.796 per share.
- The sale was to cover tax withholding obligations related to the vesting of restricted stock units and was automatic.
- Following the transaction, Sinha directly owns 1,133,139 shares of Allovir common stock.
- Sinha also has indirect beneficial ownership of 16,674,766 shares held by ElevateBio LLC, where he serves as a director and CFO.
- He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a change in the executive's confidence in the company.
Industry Context
This is a standard Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of stock sale transaction |
| 05/07/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.